Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas.


Journal

Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R

Informations de publication

Date de publication:
18 10 2022
Historique:
pubmed: 24 8 2022
medline: 22 10 2022
entrez: 23 8 2022
Statut: ppublish

Résumé

Diffuse spinal cord gliomas (SCGs) are rare tumors associated with a high morbidity and mortality that affect both pediatric and adult populations. In this retrospective study, we sought to characterize the clinical, pathological, and molecular features of diffuse SCG in 22 patients with histological and molecular analyses. The median age of our cohort was 23.64 years (range 1-82) and the overall median survival was 397 days. K27M mutation was significantly more prevalent in males compared to females. Gross total resection and chemotherapy were associated with improved survival, compared to biopsy and no chemotherapy. While there was no association between tumor grade, K27M status (p = 0.366) or radiation (p = 0.772), and survival, males showed a trend toward shorter survival. K27M mutant tumors showed increased chromosomal instability and a distinct DNA methylation signature.

Identifiants

pubmed: 35997552
pii: 6673886
doi: 10.1093/jnen/nlac075
doi:

Substances chimiques

Histones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

865-872

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of American Association of Neuropathologists, Inc. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Mekka R Garcia (MR)

Department of Neurology, NYU Langone Health, New York, New York, USA.

Yang Feng (Y)

Department of Biostatistics, NYU School of Global Public Health, New York, New York, USA.

Varshini Vasudevaraja (V)

Department of Pathology, NYU Langone Health, New York, New York, USA.

Kristyn Galbraith (K)

Department of Pathology, NYU Langone Health, New York, New York, USA.

Jonathan Serrano (J)

Department of Pathology, NYU Langone Health, New York, New York, USA.

Cheddhi Thomas (C)

Department of Pathology, NYU Langone Health, New York, New York, USA.

Alireza Radmanesh (A)

Department of Radiology, NYU Langone Health, New York, New York, USA.

Eveline T Hidalgo (ET)

Department of Neurosurgery, NYU Langone Health, New York, New York, USA.

David H Harter (DH)

Department of Neurosurgery, NYU Langone Health, New York, New York, USA.

Jeffrey C Allen (JC)

Department of Neurology, NYU Langone Health, New York, New York, USA.

Sharon L Gardner (SL)

Department of Pediatrics, NYU Langone Health, New York, New York, USA.

Diana S Osorio (DS)

Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA.

Christopher M William (CM)

Department of Pathology, NYU Langone Health, New York, New York, USA.

David Zagzag (D)

Department of Pathology, NYU Langone Health, New York, New York, USA.

Daniel R Boué (DR)

Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital and the Ohio State University, Columbus, Ohio, USA.

Matija Snuderl (M)

Department of Pathology, NYU Langone Health, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH